Prevalence and Clinicopathological Features with Oral Biological Correlates of Potentially Malignant Oral Disorders in Individuals with High-Risk Oral Habits
DOI:
https://doi.org/10.63682/jns.v14i33S.10192Keywords:
Potentially malignant oral disorders, Leukoplakia, Oral submucous fibrosisAbstract
Objective: To determine the prevalence, clinicopathological characteristics, and oral biological correlates of potentially malignant oral disorders (PMODs) in individuals with high-risk oral habits.
Materials and Methods: It was an analytical cross-sectional study carried out in a period of one year. Non-probability consecutive sampling was used to enroll 150 participants aged ≥18 years with high-risk oral habits. The oral cavity clinical examination was conducted, and a biopsy of suspected lesions was done to examine them histopathologically. SPSS version 24 was used to analyze the data. The descriptive statistics were provided in frequencies, percentages, and mean ± SD. The Chi-square test was used to assess the associations, and p ≤ 0.05 was regarded as significant.
Results: The average age of the subjects was 39.8 ± 12.4 years, and the male gender prevailed (68%). Smokeless tobacco use (34.7%) was the most common high-risk habit. PMODs were found in a quarter of the participants. The expression of Ki-67 (69.4%) was more than that of p53 (58.3), and the expression of biomarkers rose greatly as the severity of dysplasia increased (p = 0.001). There was a considerable correlation between high-risk oral habits and PMODs (p = 0.032).
Conclusions: PMODs are common in patients with high-risk oral habits, and the severity of PMODs is associated with biomarker expression. To avoid malignant transformation, early detection, quitting a habit, and a combination of clinical, pathological, and biological evaluation is needed.
Downloads
References
1.Lorini, L., et al., Overview of oral potentially malignant disorders: from risk factors to specific therapies. Cancers, 2021. 13(15): p. 3696.
2. Celentano, A. and N. Cirillo, Diseases with oral malignant potential: Need for change to inform research, policy, and practice. Journal of Oral Pathology & Medicine, 2024. 53(8): p. 495-501.
3. Kumari, P., P. Debta, and A. Dixit, Oral potentially malignant disorders: etiology, pathogenesis, and transformation into oral cancer. Frontiers in pharmacology, 2022. 13: p. 825266.
4. Filho, A.M. and S. Warnakulasuriya, Epidemiology of oral cancer in South and South‐East Asia: Incidence and mortality. Oral diseases, 2024. 30(8): p. 4847-4854.
5. Hsu, P.-C., et al., Early molecular diagnosis and comprehensive treatment of oral cancer. Current Issues in Molecular Biology, 2025. 47(6): p. 452.
6. Kidwai, Z., Oral Potentially Malignant Disorders in high-risk groups in South Asia: A novel approach to screening and the way forward. 2023, University of York.
7. Villa, A., M. Lodolo, and P. Ha, Oncological outcomes of patients with oral potentially malignant disorders. JAMA Otolaryngology–Head & Neck Surgery, 2025. 151(1): p. 65-71.
8. Chaurasia, S., et al., Exploring the spectrum of oral pathologies: A retrospective analysis of clinical and histopathological characteristics. Journal of Oral and Maxillofacial Pathology, 2025. 29(3): p. 435-440.
9. Menditti, D., et al., State of the Art in the Diagnosis and Assessment of Oral Malignant and Potentially Malignant Disorders: Present Insights and Future Outlook—An Overview. Bioengineering, 2024. 11(3): p. 228.
10. Andreichyk, K., Precancerous lesions of oral cavity. 2024.
11. Awawdeh, M.A., et al., Evaluation of prognostic significance of the expression of p53, cyclin D1, EGFR in advanced oral squamous cell carcinoma after chemoradiation—a systematic review. Applied Sciences, 2023. 13(9): p. 5292.
12. Fornias Sperandio, F., et al., Screening Tools and Strategies for Early Detection of Oral Cancer and Potentially Malignant Disorders in Rural Populations: A Systematic Review. Available at SSRN 5500182.
13. Annapoorani, S., et al., Assessment of ploidy status in oral potentially malignant disorders–a systematic review. Journal of Pharmacy and Bioallied Sciences, 2023. 15(Suppl 1): p. S86-S92.
14. Sharma, A.D., et al., PREVALENCE OF ORAL LEUKOPLAKIA, ERYTHROPLAKIA, AND ORAL SUBMUCOSUS FIBROSIS IN PATIENTS CONSUMING TOBACCO AND ARECANUT: A HOSPITAL-BASED OBSERVATIONAL STUDY. PRZEGL EPIDEMIOL, 2025. 79(2): p. 241-249.
15. Zhang, C., et al., The global prevalence of oral leukoplakia: a systematic review and meta-analysis from 1996 to 2022. BMC oral health, 2023. 23(1): p. 645.
16. Wang, M., et al., Prevalence of oral submucous fibrosis across diverse populations: a systematic review and meta-analysis. PeerJ, 2024. 12: p. e18385.
17. Venkatesh, D.P., et al., Epidemiological trends and clinicopathological characteristics of oral leukoplakia: a retrospective analysis from a single institution in Chennai, Tamil Nadu, India. Cureus, 2024. 16(6): p. e61590.
18. Jerjes, W., et al., Advancing non-invasive diagnosis of oral epithelial dysplasia: comparative insights from in vivo optical coherence tomography and histopathology. Journal of Clinical Medicine, 2025. 14(4): p. 1118.
19. Andrés-Sánchez, N., D. Fisher, and L. Krasinska, Physiological functions and roles in cancer of the proliferation marker Ki-67. Journal of cell science, 2022. 135(11): p. jcs258932.
20. Bijai, L.K., et al., Role of mast cells in the pathogenesis of oral submucous fibrosis: a systematic review and meta-analysis. BMC Oral Health, 2024. 24(1): p. 1219
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
